Sjogren-Larsson syndrome: Accumulation of free fatty alcohols in cultured fibroblasts and plasma

William B. Rizzo, Debra A. Craft

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Sjogren-Larsson syndrome (SLS) is an inherited disorder associated with deficient oxidation of long-chain aliphatic alcohols. Previous studies have reported modest elevations in total (free + esterified) fatty alcohols in SLS, but free fatty alcohols have not been selectively measured, in part because of their low concentrations in most tissues and the presence of trace fatty alcohol contaminants in some solvents used for their analysis. We adapted methods to measure free fatty alcohols in cultured cells and plasma that minimize exogenous alcohol contamination. Fatty alcohols were analyzed as acetate derivatives, using capillary column gas chromatography. By this method, cultured skin fibroblasts from SLS patients were found to have 7- and 8-fold elevations in the mean content of hexadecanol (16:0-OH) and octadecanol (18:6-OH), respectively. The mean plasma 16:0-OH and 18:0-OH concentrations in SLS patients (n = 11) were 9- and 22-fold higher than in normal controls, respectively. In SLS fibroblasts, most of the fatty alcohol (59%) that accumulated was free rather than esterified alcohol, whereas free alcohol accounted for 23% of the total alcohol in normal cells. These results indicate that elevations in free fatty alcohols provide a sensitive marker for the enzymatic defect in SLS. The ability to measure free fatty alcohols in cultured cells and plasma should prove useful for investigations of normal fatty alcohol metabolism and the deranged metabolism in SLS.

Original languageEnglish (US)
Pages (from-to)1077-1081
Number of pages5
JournalJournal of Lipid Research
Volume41
Issue number7
StatePublished - Jul 1 2000

Fingerprint

Sjogren-Larsson Syndrome
Fatty Alcohols
Fibroblasts
Plasmas
Alcohols
Metabolism
Cultured Cells
Cells
Column chromatography
Gas chromatography
Gas Chromatography
Skin
Acetates
Contamination

Keywords

  • Ether lipids
  • Ichthyosis
  • Mental retardation
  • Metabolic disease
  • Spasticity
  • Wax esters

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Sjogren-Larsson syndrome : Accumulation of free fatty alcohols in cultured fibroblasts and plasma. / Rizzo, William B.; Craft, Debra A.

In: Journal of Lipid Research, Vol. 41, No. 7, 01.07.2000, p. 1077-1081.

Research output: Contribution to journalArticle

@article{d6db2d78216141718c96f817beddd933,
title = "Sjogren-Larsson syndrome: Accumulation of free fatty alcohols in cultured fibroblasts and plasma",
abstract = "Sjogren-Larsson syndrome (SLS) is an inherited disorder associated with deficient oxidation of long-chain aliphatic alcohols. Previous studies have reported modest elevations in total (free + esterified) fatty alcohols in SLS, but free fatty alcohols have not been selectively measured, in part because of their low concentrations in most tissues and the presence of trace fatty alcohol contaminants in some solvents used for their analysis. We adapted methods to measure free fatty alcohols in cultured cells and plasma that minimize exogenous alcohol contamination. Fatty alcohols were analyzed as acetate derivatives, using capillary column gas chromatography. By this method, cultured skin fibroblasts from SLS patients were found to have 7- and 8-fold elevations in the mean content of hexadecanol (16:0-OH) and octadecanol (18:6-OH), respectively. The mean plasma 16:0-OH and 18:0-OH concentrations in SLS patients (n = 11) were 9- and 22-fold higher than in normal controls, respectively. In SLS fibroblasts, most of the fatty alcohol (59{\%}) that accumulated was free rather than esterified alcohol, whereas free alcohol accounted for 23{\%} of the total alcohol in normal cells. These results indicate that elevations in free fatty alcohols provide a sensitive marker for the enzymatic defect in SLS. The ability to measure free fatty alcohols in cultured cells and plasma should prove useful for investigations of normal fatty alcohol metabolism and the deranged metabolism in SLS.",
keywords = "Ether lipids, Ichthyosis, Mental retardation, Metabolic disease, Spasticity, Wax esters",
author = "Rizzo, {William B.} and Craft, {Debra A.}",
year = "2000",
month = "7",
day = "1",
language = "English (US)",
volume = "41",
pages = "1077--1081",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "7",

}

TY - JOUR

T1 - Sjogren-Larsson syndrome

T2 - Accumulation of free fatty alcohols in cultured fibroblasts and plasma

AU - Rizzo, William B.

AU - Craft, Debra A.

PY - 2000/7/1

Y1 - 2000/7/1

N2 - Sjogren-Larsson syndrome (SLS) is an inherited disorder associated with deficient oxidation of long-chain aliphatic alcohols. Previous studies have reported modest elevations in total (free + esterified) fatty alcohols in SLS, but free fatty alcohols have not been selectively measured, in part because of their low concentrations in most tissues and the presence of trace fatty alcohol contaminants in some solvents used for their analysis. We adapted methods to measure free fatty alcohols in cultured cells and plasma that minimize exogenous alcohol contamination. Fatty alcohols were analyzed as acetate derivatives, using capillary column gas chromatography. By this method, cultured skin fibroblasts from SLS patients were found to have 7- and 8-fold elevations in the mean content of hexadecanol (16:0-OH) and octadecanol (18:6-OH), respectively. The mean plasma 16:0-OH and 18:0-OH concentrations in SLS patients (n = 11) were 9- and 22-fold higher than in normal controls, respectively. In SLS fibroblasts, most of the fatty alcohol (59%) that accumulated was free rather than esterified alcohol, whereas free alcohol accounted for 23% of the total alcohol in normal cells. These results indicate that elevations in free fatty alcohols provide a sensitive marker for the enzymatic defect in SLS. The ability to measure free fatty alcohols in cultured cells and plasma should prove useful for investigations of normal fatty alcohol metabolism and the deranged metabolism in SLS.

AB - Sjogren-Larsson syndrome (SLS) is an inherited disorder associated with deficient oxidation of long-chain aliphatic alcohols. Previous studies have reported modest elevations in total (free + esterified) fatty alcohols in SLS, but free fatty alcohols have not been selectively measured, in part because of their low concentrations in most tissues and the presence of trace fatty alcohol contaminants in some solvents used for their analysis. We adapted methods to measure free fatty alcohols in cultured cells and plasma that minimize exogenous alcohol contamination. Fatty alcohols were analyzed as acetate derivatives, using capillary column gas chromatography. By this method, cultured skin fibroblasts from SLS patients were found to have 7- and 8-fold elevations in the mean content of hexadecanol (16:0-OH) and octadecanol (18:6-OH), respectively. The mean plasma 16:0-OH and 18:0-OH concentrations in SLS patients (n = 11) were 9- and 22-fold higher than in normal controls, respectively. In SLS fibroblasts, most of the fatty alcohol (59%) that accumulated was free rather than esterified alcohol, whereas free alcohol accounted for 23% of the total alcohol in normal cells. These results indicate that elevations in free fatty alcohols provide a sensitive marker for the enzymatic defect in SLS. The ability to measure free fatty alcohols in cultured cells and plasma should prove useful for investigations of normal fatty alcohol metabolism and the deranged metabolism in SLS.

KW - Ether lipids

KW - Ichthyosis

KW - Mental retardation

KW - Metabolic disease

KW - Spasticity

KW - Wax esters

UR - http://www.scopus.com/inward/record.url?scp=0033624142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033624142&partnerID=8YFLogxK

M3 - Article

C2 - 10884288

AN - SCOPUS:0033624142

VL - 41

SP - 1077

EP - 1081

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 7

ER -